The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
Open accessAbstract
BACKGROUND: Atherosclerotic intracranial arterial stenosis is an important cause of stroke. Warfarin is commonly used in preference to aspirin for this disorder, but these therapies have not been compared in a randomized trial. METHODS: We randomly assigned patients with transient ischemic attack or stroke caused by angiographically verified 50 to 99 percent stenosis of a major intracranial artery to receive warfarin (target international normalized ratio, 2.0 to 3.0) or aspirin (1300 mg per day) in a double-blind, multicenter clinical trial. The primary end point was ischemic stroke, brain hemorrhage, or death from vascular causes other than stroke. RESULTS: After 569 patients had undergone randomization, enrollment was stopped because of concerns about the safety of the patients who had been assigned to receive warfarin. During a mean follow-up period of 1.8 years, adverse events in the two groups included death (4.3 percent in the aspirin group vs. 9.7 percent in the warfarin group; hazard ratio for aspirin relative to warfarin, 0.46; 95 percent confidence interval, 0.23 to 0.90; P=0.02), major hemorrhage (3.2 percent vs. 8.3 percent, respectively; hazard ratio, 0.39; 95 percent confidence interval, 0.18 to 0.84; P=0.01), and myocardial infarction or sudden death (2.9 percent vs. 7.3 percent, respectively; hazard ratio, 0.40; 95 percent confidence interval, 0.18 to 0.91; P=0.02). The rate of death from vascular causes was 3.2 percent in the aspirin group and 5.9 percent in the warfarin group (P=0.16); the rate of death from nonvascular causes was 1.1 percent and 3.8 percent, respectively (P=0.05). The primary end point occurred in 22.1 percent of the patients in the aspirin group and 21.8 percent of those in the warfarin group (hazard ratio, 1.04; 95 percent confidence interval, 0.73 to 1.48; P=0.83). CONCLUSIONS: Warfarin was associated with significantly higher rates of adverse events and provided no benefit over aspirin in this trial. Aspirin should be used in preference to warfarin for patients with intracranial arterial stenosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis
Barnett, H. J. M., Taylor, D. W., Eliasziw, M., Fox, A. J., Ferguson, G. G., Haynes, R. B., Rankin, R. N., Clagett, G. P., Hachinski, V. C., Sackett, D. L., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811123392002 · Cited by 3,594
The Statistical Analysis of Failure Time Data
Klein, J. P. (1982) · Technometrics · doi:10.1080/00401706.1982.10487769 · Cited by 2,215
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,065
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
The Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., & Hylek, E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.204s · Cited by 1,528
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
WALKER, M. D., Marler, J. R., Goldstein, M., Grady, P. A., Toole, J. F., Baker, W. H., Castaldo, J., Chambless, L. E., Moore, W. S., Robertson, J. T., et al. (1995) · JAMA · doi:10.1001/jama.273.18.1421 · Cited by 1,334
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
Mohr, J. P., Thompson, J. L. P., Lazar, R. M., Levin, B., Sacco, R. L., Furie, K. L., Kistler, J. P., Albers, G. W., Pettigrew, L. C., Adams, H. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011258 · Cited by 1,168
Cited by
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Self-citationKleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Self-citationGuidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., & Palareti, G. (2008) · Chest · doi:10.1378/chest.08-0670 · Cited by 2,118
Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis
Chimowitz, M. I., Lynn, M. J., Derdeyn, C. P., Turan, T. N., Fiorella, D., Lane, B. F., Janis, L. S., Lutsep, H. L., Barnwell, S. L., Waters, M. F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105335 · Cited by 1,901
Self-citationSacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Stroke · doi:10.1161/01.str.0000199147.30016.74 · Cited by 1,873
Attia, Z. I., Noseworthy, P. A., Lopez-Jimenez, F., Asirvatham, S. J., Deshmukh, A. J., Gersh, B. J., Carter, R. E., Yao, X., Rabinstein, A. A., Erickson, B. J., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31721-0 · Cited by 1,613
The Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., & Hylek, E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.204s · Cited by 1,528
Furie, K. L., Kasner, S. E., Adams, R. J., Albers, G. W., Bush, R. L., Fagan, S. C., Halperin, J. L., Johnston, S. C., Katzan, I., Kernan, W. N., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181f7d043 · Cited by 1,492
Self-citationAspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Sacco, R. L., Diener, H.-C., Yusuf, S., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805002 · Cited by 961
Antithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M., Werring, D., et al. (2018) · Chest · doi:10.1016/j.chest.2018.07.040 · Cited by 939
Antithrombotic Therapy for Atrial Fibrillation
You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., Hylek, E. M., Schulman, S., Go, A. S., Hughes, M., et al. (2012) · Chest · doi:10.1378/chest.11-2304 · Cited by 918
Derdeyn, C. P., Chimowitz, M. I., Lynn, M. J., Fiorella, D., Turan, T. N., Janis, L. S., Montgomery, J., Nizam, A., Lane, B. F., Lutsep, H. L., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62038-3 · Cited by 881
Self-citationBrott, T. G., Halperin, J. L., Abbara, S., Bacharach, J. M., Barr, J. D., Bush, R. L., Cates, C. U., Creager, M. A., Fowler, S. B., Friday, G., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820d8d78 · Cited by 797
Self-citationPredictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial Stenosis
Kasner, S. E., Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., Stern, B. J., Hertzberg, V. S., Frankel, M. R., Levine, S. R., Chaturvedi, S., Benesch, C. G., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.578229 · Cited by 759
Self-citationHemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
Schulman, S., Beyth, R. J., Kearon, C., & Levine, M. N. (2008) · Chest · doi:10.1378/chest.08-0674 · Cited by 740
Gorelick, P. B., Wong, K. S., Bae, H.-J., & Pandey, D. K. (2008) · Stroke · doi:10.1161/strokeaha.107.505776 · Cited by 661
Zaidat, O. O., Fitzsimmons, B.-F., Woodward, B. K., Wang, Z., Killer-Oberpfalzer, M., Wakhloo, A., Gupta, R., Kirshner, H., Megerian, J. T., Lesko, J., et al. (2015) · JAMA · doi:10.1001/jama.2015.1693 · Cited by 620
Innovative Interventional and Imaging Registries: Precision Medicine in Cerebrovascular Disorders
Liebeskind, D. S. (2015) · Interventional Neurology · doi:10.1159/000438773 · Cited by 608
Alberts, M. J., Latchaw, R. E., Selman, W. R., Shephard, T., Hadley, M. N., Brass, L. M., Koroshetz, W., Marler, J. R., Booss, J., Zorowitz, R. D., et al. (2005) · Stroke · doi:10.1161/01.str.0000170622.07210.b4 · Cited by 585
Global Burden of Intracranial Atherosclerosis
Wong, L. K. S. (2006) · International Journal of Stroke · doi:10.1111/j.1747-4949.2006.00045.x · Cited by 574
Independent predictors of stroke in patients with atrial fibrillation: A systematic review
The Stroke Risk in Atrial Fibrillation Working Group (2007) · Neurology · doi:10.1212/01.wnl.0000267275.68538.8d · Cited by 547
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Circulation · doi:10.1161/circ.113.10.e409 · Cited by 541
Brott, T. G., Halperin, J. L., Abbara, S., Bacharach, J. M., Barr, J. D., Bush, R. L., Cates, C. U., Creager, M. A., Fowler, S. B., Friday, G., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.005 · Cited by 526
Self-citationSavitz, S. I., & Caplan, L. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041544 · Cited by 485
Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment
Holmstedt, C. A., Turan, T. N., & Chimowitz, M. I. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70195-9 · Cited by 484
Self-citationThe increasing incidence of anticoagulant-associated intracerebral hemorrhage
Flaherty, M. L., Kissela, B., Woo, D., Kleindorfer, D., Alwell, K., Sekar, P., Moomaw, C. J., Haverbusch, M., & Broderick, J. P. (2007) · Neurology · doi:10.1212/01.wnl.0000250340.05202.8b · Cited by 482
Brott, T. G., Halperin, J. L., Abbara, S., Bacharach, J. M., Barr, J. D., Bush, R. L., Cates, C. U., Creager, M. A., Fowler, S. B., Friday, G., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.006 · Cited by 447
Self-citationStroke Caused by Atherosclerosis of the Major Intracranial Arteries
Banerjee, C., & Chimowitz, M. I. (2017) · Circulation Research · doi:10.1161/circresaha.116.308441 · Cited by 437
Self-citationWong, K. S. L., Chen, C., Fu, J., Chang, H. M., Suwanwela, N. C., Huang, Y. N., Han, Z., Tan, K. S., Ratanakorn, D., Chollate, P., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70060-0 · Cited by 417
Bose, A., Hartmann, M., Henkes, H., Liu, H. M., Teng, M. M. H., Szikora, I., Berlis, A., Reul, J., Yu, S. C. H., Forsting, M., et al. (2007) · Stroke · doi:10.1161/strokeaha.106.477711 · Cited by 405
Qureshi, A. I., & Caplan, L. R. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61088-0 · Cited by 395
Analysis of Thrombi Retrieved From Cerebral Arteries of Patients With Acute Ischemic Stroke
Marder, V. J., Chute, D. J., Starkman, S., Abolian, A. M., Kidwell, C., Liebeskind, D., Ovbiagele, B., Vinuela, F., Duckwiler, G., Jahan, R., et al. (2006) · Stroke · doi:10.1161/01.str.0000230307.03438.94 · Cited by 394
Touzé, E., Varenne, O., Chatellier, G., Peyrard, S., Rothwell, P. M., & Mas, J.-L. (2005) · Stroke · doi:10.1161/01.str.0000190118.02275.33 · Cited by 384
Kamel, H., Longstreth, W., Tirschwell, D. L., Kronmal, R. A., Broderick, J. P., Palesch, Y. Y., Meinzer, C., Dillon, C., Ewing, I., Spilker, J. A., et al. (2019) · International Journal of Stroke · doi:10.1177/1747493018799981 · Cited by 380
Self-citationPrimary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage
Diener, H.-C., & Hankey, G. J. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.072 · Cited by 364
Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas
Hart, R. G., Tonarelli, S. B., & Pearce, L. A. (2005) · Stroke · doi:10.1161/01.str.0000170642.39876.f2 · Cited by 355
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
Meadows, T. A., & Bhatt, D. L. (2007) · Circulation Research · doi:10.1161/01.res.0000264509.36234.51 · Cited by 351
The NIH registry on use of the Wingspan stent for symptomatic70–99% intracranial arterial stenosis
Zaidat, O. O., Klucznik, R., Alexander, M. J., Chaloupka, J., Lutsep, H., Barnwell, S., Mawad, M., Lane, B., Lynn, M. J., & Chimowitz, M. (2008) · Neurology · doi:10.1212/01.wnl.0000306308.08229.a3 · Cited by 341
Self-citationThe Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) Trial
Feldmann, E., Wilterdink, J. L., Kosinski, A., Lynn, M., Chimowitz, M. I., Sarafin, J., Smith, H. H., Nichols, F., Rogg, J., Cloft, H. J., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261488.05906.c1 · Cited by 338
Self-citationFiorella, D., Levy, E. I., Turk, A. S., Albuquerque, F. C., Niemann, D. B., Aagaard-Kienitz, B., Hanel, R. A., Woo, H., Rasmussen, P. A., Hopkins, L. N., et al. (2007) · Stroke · doi:10.1161/01.str.0000257963.65728.e8 · Cited by 337
Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment
Gutierrez, J., Turan, T. N., Hoh, B. L., & Chimowitz, M. I. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00376-8 · Cited by 321
Self-citationWEAVE Trial: Final Results in 152 On-Label Patients
Alexander, M. J., Zauner, A., Chaloupka, J. C., Baxter, B., Callison, R. C., Gupta, R., Song, S. S., Yu, W., on behalf of the WEAVE Trial Investigators, Feng, L., et al. (2019) · Stroke · doi:10.1161/strokeaha.118.023996 · Cited by 320
Collaterals dramatically alter stroke risk in intracranial atherosclerosis
Liebeskind, D. S., Cotsonis, G. A., Saver, J. L., Lynn, M. J., Turan, T. N., Cloft, H. J., Chimowitz, M. I., & for the Warfarin–Aspirin Symptomatic Intracranial Disease (WASID) Investigators (2011) · Annals of Neurology · doi:10.1002/ana.22354 · Cited by 309
Self-citationProspective study of symptomatic atherothrombotic intracranial stenoses: The GESICA Study
Mazighi, M., Tanasescu, R., Ducrocq, X., Vicaut, E., Bracard, S., Houdart, E., & Woimant, F. (2006) · Neurology · doi:10.1212/01.wnl.0000208404.94585.b2 · Cited by 307
Gao, P., Wang, T., Wang, D., Liebeskind, D. S., Shi, H., Li, T., Zhao, Z., Cai, Y., Wu, W., He, W., et al. (2022) · JAMA · doi:10.1001/jama.2022.12000 · Cited by 286
Alexandrov, A. V., Sloan, M. A., Tegeler, C. H., Newell, D. N., Lumsden, A., Garami, Z., Levy, C. R., Wong, L. K. S., Douville, C., Kaps, M., et al. (2012) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2010.00523.x · Cited by 272
Brott, T. G., Halperin, J. L., Abbara, S., Bacharach, J. M., Barr, J. D., Bush, R. L., Cates, C. U., Creager, M. A., Fowler, S. B., Friday, G., et al. (2013) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22983 · Cited by 253
Self-citationAguilar, M. I., & Hart, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001927.pub2 · Cited by 252
Khan, A., Kasner, S. E., Lynn, M. J., & Chimowitz, M. I. (2012) · Stroke · doi:10.1161/strokeaha.111.641696 · Cited by 47
Self-citation
Metadata
- Authors
- Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., Stern, B. J., Hertzberg, V. S., Frankel, M. R., Levine, S. R., Chaturvedi, S., Kasner, S. E., Benesch, C. G., Sila, C. A., Jovin, T. G., & Romano, J. G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-03-31
- Volume
- 352
- Issue
- 13
- Pages
- 1305-1316
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2167806412
- Cited by
- 1,744
- References
- 39
- FWCI
- 68.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.